Biomarkers

P003 - Blood Neurofilament Light Chain Levels And Association With Brain Volume Change In Patients With Ppms And Rms Before And Under Treatment With Ocrelizumab

Presenter
  • A. Bar-Or
Author
  • A. Bar-Or
  • A. Herman
  • C. Harp
  • A. Cross
  • D. Fiore
  • S. Hauser
  • L. Kappos
  • H. Koendgen
  • J. Kuhle
  • D. Leppert
  • M. Manfrini
  • F. Model
  • J. Oksenberg
  • A. Sauter
  • G. Thanei
  • X. Jia
Session Title
Poster Session 1 / Opening Networking Event

Previous ePoster
P002 - Baseline Cerebral Metabolism Predicts Fatigue And Cognition In Multiple Sclerosis Patients

Next ePoster

No Preview Available
P004 - Can T Cell Migratory Signature Predict MS Disease Progression?
No Preview Available
P005 - Can We Predict Long-Term MS Outcomes With A Blood Test?
P006 - Coagulation Activation And Cerebral Hypoperfusion In Relapsing-remitting Multiple Sclerosis
P007 - Classification Of High Versus Low Annualized Relapse Rate Status In Subjects With Relapsing-Remitting Multiple Sclerosis Using Multivariate Serum Protein Biomarker Models
P008 - Differential Expression Of Gene Splice Variants In Macrophages From Multiple Sclerosis Patients In An Underrepresented Minority Population
No Preview Available
P009 - Effect Of Interferon β-1a Treatment On Serum Neurofilament Light-chain Levels In Patients With A First Clinical Demyelinating Event In The REFLEX Trial
P010 - Gd+ Lesions Impacts On The Association Between Age And Serum Neurofilament Light In Patients With Multiple Sclerosis
P011 - Higher Sensitivity Of Quantitative RT-PCR Compared With Flow Cytometry For Quantification Of B Cells After Anti-CD20 Monoclonal Antibody Therapy
No Preview Available
P013 - Metabolic Network Alterations In Multiple Sclerosis And Correlation With Disease Severity
P014 - Multi-layer Analysis Of Quantitative 7t Mri In The Cortex Of Multiple Sclerosis Patients Reveals Pathology Associated With Disability